サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Hematology Analyzer Instrumentation and Reagent Markets

血液分析装置、試薬市場

レポート概要

臨床血液分析は臨床検査分析の最も重要なセクターの一つです。血液分析装置、試薬市場はヘマトロジー・アナライザーと呼ばれる検査装置が中心となっています。臨床血液分析装置という用語は通常、血液のように容易に採取できる体液における細胞成分の存在、数、種類を調べる自動分析装置のことを意味しますが、必ずしもこれらの検査に限られる訳ではありません。血液分析にはヘモグロビンやヘマトクリットといった、血液中の非細胞パラメータの検査が必ず含まれます。その他、臨床的に密接な関連がある分野は凝固とフローサイトメトリーです。

実際、微生物学、血液学、血液銀行、免疫学、さらに解剖病理学でさえ運営、機器の両面で急速に衰退しています。但し、テーマを妥当な範囲に絞るために、より伝統的な臨床血液分析装置を中心に調査を行います。このレポートは世界の臨床血液分析装置、試薬市場の特定セグメントについて解説し、革新と成長という意味で特に活発な分野を取り上げます。具体的には、小規模検査室のほか、非常に自動化された大規模検査機関、さらにOEMメーカーの試薬、供給品、アドオン機器といった付属設備について詳細な調査、分析を行います。

レポート詳細

サンプルを見る

※このサンプルは会員登録をしなくてもご覧いただけます。

目次

TABLE OF CONTENTS

1. Overview
1.1 Objectives of the Report
1.2 Methodology
1.3 Scope of the Report
1.4 Executive Summary

2. IVD Clinical Hematology Analyzer Market
2.1 Introduction
2.2 Key Product Segments
2.2.1 Hematology and Associates Instruments
2.2.1.1 Hematology Analyzers
2.2.1.2 Hematology Instruments Offerings by Major Players
2.2.1.2.1 Hematology Reagents and Controls
2.2.1.2.2 Hematology Point of Care Instruments
2.2.1.3 Flow Cytometers
2.2.1.3.1 Flow Cytometry Technology Platforms
2.2.1.3.2 Clinical Applications of Flow Cytometry
2.2.1.3.2.1 Leukocyte Analysis
2.2.1.3.2.2 Immunophenotyping of Leukemias and Lymphomas
2.2.1.3.2.3 Neutropenia
2.2.1.3.2.4 Platelet Analysis
2.2.1.3.2.5 T Cell Subsets
2.2.1.3.2.6 Reticulocyte Count
2.2.1.3.3 Flow Cytometry Market Growth
2.2.1.3.3.1 Applications
2.2.1.3.3.2 Market Size
2.2.1.3.3.3 Instrumentation Preferences
2.2.1.3.3.4 Reagent Selection and Use
2.2.1.3.3.5 Instrument Manufacturers
2.2.1.3.3.6 Future Directions of Flow Cytometry
2.2.1.4 Coagulation Analyzers
2.2.1.4.1 Coagulation Market Size
2.2.1.4.2 Prothrombin Time Test
2.2.1.4.3 Activated Partial Thromboplastin Time (APTT)
2.2.1.4.4 Clinical Advantages of Coagulation Testing
2.2.1.4.5 Coagulation Instruments
2.2.1.4.5.1 Roche Diagnostics
2.2.1.4.5.2 Avocet Medical (Acquired by Beckman Coulter, Inc.)
2.2.1.4.5.3 International Technidyne Corporation (ITC)
2.2.1.4.5.4 Diagnostica Stago's STA-RE Evolution
2.2.1.4.5.5 Other Companies
2.2.1.4.5.6 Coagulation Reagents
2.2.1.5 Hemoglobinometers
2.2.1.6 Slide Stainers
2.2.1.7 Differential Counters
2.2.1.8 Hematology Stains
2.3 Blood Components
2.3.1 Complete Blood Count (CBC)
2.3.2 Red Blood Cells (RBCs)
2.3.3 White Blood Cells (WBCs)
2.3.4 Platelets
2.3.5 Hematocrit (HCT)
2.4 Hematology Tests
2.5 The Coulter Principle
2.6 Blood Collection

3. Global Analyzer Market
3.1 Global Markets
3.1.1 Global Drivers of Clinical Hematology Analyzer Testing
3.1.2 Global Outlook
3.1.3 U.S. Market
3.1.4 European Market
3.1.5.1 German Clinical Hematology Analyzer and Reagent Diagnostic Markets
3.1.5.2 U.K. Clinical Hematology Market
3.1.5.3 French Clinical Hematology Market
3.1.5.4 Italian Clinical Hematology Market
3.1.5.5 Spanish Clinical Hematology Market
3.1.5.6 Belgian Clinical Hematology Market
3.1.5.7 Swiss Clinical Hematology Market
3.1.5.8 Dutch Clinical Hematology Market
3.1.5.9 Portuguese Clinical Hematology Market
3.1.5.10 Austrian Clinical Hematology Market
3.1.5.11 Greek Clinical Hematology Market
3.1.5.12 Polish Clinical Hematology Market
3.1.5.13 Czech Clinical Hematology Market
3.1.5.14 Finnish Clinical Hematology Market
3.1.5.15 Scandinavian Clinical Hematology Market
3.1.6 Asian Market
3.1.6.1 Indian Clinical Hematology Market
3.1.6.1.1 India's in vitro Diagnostic Testing Industry
3.1.6.1.2 Major Indian IVD Companies
3.1.6.2 Japanese Clinical Hematology Market
3.1.6.3 Chinese Clinical Hematology Market
3.1.7 Country Clinical Hematology Smaller Markets
3.1.7.1 Canada Clinical Hematology Market
3.1.7.2 Brazil Clinical Hematology Market
3.1.7.3 Turkey Clinical Hematology Market
3.1.7.4 Australia Clinical Hematology Market
3.1.8 Remaining World Clinical Hematology Market
3.1.9 Overview of Asian Healthcare Market
3.1.9.1 Singapore
3.1.9.2 Malaysia
3.1.9.3 Thailand
3.1.9.4 Indonesia
3.1.9.5 Philippines
3.1.9.6 South Korea
3.1.9.7 Hong Kong
3.1.10 Overview of the Latin American Diagnostics Market
3.2 Clinical Hematology Analyzer and Reagents Sector
3.2.1 Industry-Served Markets
3.2.2 Industry Players
3.2.2.1 Manufacturing Companies
3.2.3 Market Specialization
3.2.4 Hematology Sector Companies
3.3 Outlook for Clinical Hematology Analyzer Testing
3.3.1 Long-Term Changes
3.3.2 Market Drivers
3.3.3 The Limits to Growth
3.3.4 Hot Sectors in the IVD Market
3.3.5 Key Technologies
3.3.6 Conclusion

4. Clinical Hematology Instrument Market by Type and Competitor
4.1 Abbott Diagnostics
4.2 Siemens Healthcare Diagnostics
4.3 Beckman Coulter, Inc.
4.4 Drew Scientific Group
4.5 Horiba ABX Inc.
4.6 Sysmex Corporation
4.7 Boule Medical AB
4.8 Beijing ShiningSun Technology Co., Ltd.
4.9 Hematology Analyzers for Point of Care

5. Important Technology Trends
5.1 Technology Platform Innovations in Hematology Testing
5.2 The New Paradigm
5.3 Consolidated Workstations
5.4 Automation in the Laboratory
5.5 Laboratory Information Systems
5.6 New User-friendly Interfaces
5.7 Data-Management Issues
5.7.1 Wireless LANs
5.7.2 Data and Workflow Management Systems
5.7.3 Beckman Central Command Central Version 2.0
5.7.4 Middleware
5.8 Robotics - Total Laboratory Automation Robotic Sample Handling
5.9 Image Analysis
5.10 Flow Cytometry
5.11 Laser Technology
5.12 Automating Preanalytics
5.13 Telepathology

6. Business Trends in the Clinical Hematology Analyzer Sector
6.1 Key Developments
6.2 Industrial Sector Consolidation
6.3 Hospital and Commercial Laboratory Consolidation
6.4 Changing Ordering Patterns
6.5 New Products
6.6 Acquisition, License Agreements, Internal Development and Partnerships
6.7 Breadth of Product Offerings
6.8 Government Regulation
6.8.1 U.S. Regulation
6.8.1.1 Importing Medical Devices into the U.S.
6.8.1.2 Exporting Medical Devices from the U.S.
6.8.2 U.K. Regulation
6.8.3 E.U. Regulation
6.8.4 Japanese Regulation
6.8.5 Korean Regulation
6.9 Costs of Doing Business in Europe
6.10 Drivers of European Diagnostics Testing
6.11 European Reimbursement Practices
6.12 Cost Containment in Europe
6.13 Revenue and Reimbursement

7. Product Launches
7.1 Horiba ABX Unveils Pentra DX 120
7.2 Sysmex to Launch Sales of the XT-4000i Hematology Analyzers
7.3 Laser Scan Cytometry System
7.4 Abbott Receives Clearance for Hematology Instrument
7.5 Vital Diagnostics announced the Addition of the Excyte Mini Automated ESR Analyzer
7.6 Becton Introduces FACSCanto II
7.7 Abbott's International Launch of CELL-DYN Emerald? Hematology Instrument
7.8 Beckman Coulter Launches UniCel DxH 800
7.9 Beckman Launches High-Performance Hematology Analyzer AcoT
7.10 Abbott Laboratories Released its Cell-Dyn 1800 Automated Hematology Analyzer.
7.11 BD (Becton Dickinson Biosciences) Imagn System
7.12 Sysmex Network Communications System
7.13 Sysmex XT-V Multi-Species Hematology Analyzer
7.14 The Melet Schloesing MS4-5
7.15 Roche CoaguChek XS Plus System
7.16 Sysmex Corp Launches KX-4500
7.17 Streck nRBC-Chex
7.18 HORIBA ABX Introduces Micros CRP 200
7.19 Heska Corporation Introduces Veterinary Hematology Analyzer
7.20 Specialized Master Software Programs for the Sysmex XE-2100 Hematology Analyzers
7.21 HORIBA ABX e-Sat module
7.22 Medonic M series Hematology Analyzer
7.23 Streck's ESR-AutoPlus
7.24 Streck Quality Control Reagents

8. Clinical Hematology Testing Sector Trends and Forecasts
8.1 Home Care Analysis
8.2 Non-Traditional Collection for Hematology Analyzer Testing
8.3 New Systems for Critical-Care and Near-Patient Testing
8.4 Utility of Near-Patient Testing in Critical-Care Settings
8.5 Mergers of Diagnostic Companies
8.6 Information Management Advances
8.7 Test Ordering Patterns
8.8 Patient Satisfaction
8.9 Move Away From Central Laboratory
8.10 Healthcare Cost Controls
8.11 Competition for Services
8.12 Drivers of Clinical Hematology analyzer Testing
8.13 Confluence of New Technology
8.14 New Trends in Clinical Laboratory Testing
8.14.1 Trends in Reimbursement Practices
8.14.2 Managed Care
8.14.3 Changes in Patient Management
8.14.4 Focused Testing
8.14.5 Satellite Facilities
8.15 Demographic Trends

9. Company Profiles
9.1 Abbott Diagnostics
9.2 A.Menarini Diagnostics
9.3 Bayer HealthCare, AG
9.4 Beckman Coulter, Inc.
9.5 Becton Dickenson Biosciences
9.6 Boule Diagnostics International AB
9.7 Cholestech Corporation
9.8 Dade Behring (Acquired by Siemens)
9.9 HemoCue, Inc.
9.10 Heska Corporation
9.11 Horiba Group
9.12 MELET SCHLOESING Laboratories
9.13 Micronics, Inc.
9.14 Nihon Kohden Corporation
9.15 PPD (Pharmaceutical Product Development, Inc.)
9.16 Roche Diagnostics (F. Hoffmann-La Roche, Ltd.)
9.17 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
9.18 Streck, Inc.
9.19 Sysmex Corporation

LIST OF TABLES
Table 2.1: Clinical Hematology Tests Submitted to Medicare, 2005-2012
Table 2.2: Clinical Hematology Tests Performed in the U.S., 2005-2012
Table 2.3: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2009
Table 2.4: Competitive Landscape: Companies Participating in the Hematology IVD Sector
Table 2.5: Key Product Segments
Table 2.6: Worldwide Market for Flow Cytometry Instruments and Reagents, 2000-2010
Table 2.7: Worldwide Market for Rapid Coagulation Testing Dollar Volume, 2000-2008
Table 2.8: U.S. Market for Rapid Coagulation Testing Dollar Volume, 2000-2008
Table 2.9: U.S. Market for Rapid Coagulation POC Testing Dollar Volume, 2001-2012
Table 2.10: Slide Stainer Instruments and Manufacturers
Table 2.11: Hematology Stains
Table 3.1: The Overall In Vitro Diagnostic Testing Market Worldwide, 2008
Table 3.2: Worldwide Distribution of IVD Testing, 2008
Table 3.3: Global Clinical Hematology Analyzer and Reagent Revenues, 2005-2012
Table 3.4: Worldwide Distribution of Clinical Hematology Testing Analyzer and Reagent Revenues, 2006
Table 3.5: Ten Largest Diagnostic Companies Worldwide, 2007
Table 3.6 Key Players in Worldwide Hematology Analyzers and Reagent Market
Table 3.7: Leading Players in Worldwide Coagulation Analyzer and Reagent Market
Table 3.8: U.S. Clinical Hematology Analyzer Testing Market, 2000-2011
Table 3.9: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2007
Table 3.10: Leading Players in the U.S. Hematology Analyzers Market
Table 3.11: Leading Players in the U.S. Coagulation Analyzers Market
Table 3.12: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
Table 3.14: European Clinical Laboratory Testing Diagnostics by Country Market Estimates, 2007
Table 3.15: European Clinical Hematology Instrument and Reagent Testing Market, 2000-2008
Table 3.16: German Hematology Reagent Market Sales, 2003-2012
Table 3.17: UK Hematology Reagent Market Sales, 2003-2012
Table 3.18: French Hematology Reagent Market Sales, 2003-2012
Table 3.19: Italian Hematology Reagent Market Sales, 2003-2012
Table 3.20: Spanish Hematology Reagent Market Sales, 2003-2012
Table 3.21: Belgian Hematology Reagent Market Sales, 2003-2012
Table 3.22: Swiss Hematology Reagent Market Sales, 2003-2012
Table 3.23: Dutch Hematology Reagent Market Sales, 2003-2012
Table 3.24: Portuguese Hematology Reagent Market Sales, 2003-2012
Table 3.25: Austrian Hematology Reagent Market Sales, 2003-2012
Table 3.26: Greek Hematology Reagent Market Sales, 2003-2012
Table 3.27: Polish Hematology Reagent Market Sales, 2003-2012
Table 3.28: Czech Hematology Reagent Market Sales, 2003-2012
Table 3.29: Finnish Hematology Reagent Market Sales, 2003-2012
Table 3.30: Scandinavian Clinical Hematology Diagnostics Products Market Sales, 2002-2008
Table 3.31: Indian IVD Market, 2006-2012
Table 3.32: Indian Hematology Reagent Market Sales, 2006-2012
Table 3.33: Number of Automated Clinical Labs in India, 2004-2012
Table 3.34: Indian IVD Market, 2008
Table 3.36: Japanese Clinical Hematology Testing Market, 2000-2008
Table 3.37: Chinese Clinical Hematology Reagent Market Sales, 2000-2008
Table 3.38: Canadian Clinical Hematology Testing Market, 2000-2008
Table 3.39: Brazilian Clinical Hematology Analyzer Testing Market, 2000-2008
Table 3.40: Turkish Clinical Hematology Reagents Testing Market, 2000-2008
Table 3.41: Australian Clinical Hematology Reagents Testing Market, 2000-2008
Table 3.42: The ROW Clinical Hematology Reagents Testing Market, 2000-2008
Table 3.43: Estimated Number of Clinical Laboratories in Latin America
Table 3.44: Principal Marketers of Automated Clinical Hematology Analyzer Instruments
Table 4.1: Linearity and Precision of Abbott CELL-DYN Hematology Analyzers
Table 4.2: Accuracy of the Automated Differential of Abbott CELL-DYN Analyzers
Table 4.3: Linearity and Precision of Siemens Hematology Analyzers
Table 4.4: Accuracy of the Automated Differential of Siemens Hematology Analyzers
Table 4.5: Linearity and Precision of Beckman Coulter Hematology Instruments
Table 4.6: Accuracy of the Automated Differential of Beckman Coulter Hematology Analyzers
Table 4.7: Linearity and Precision of Horiba ABX Hematology Analyzers
Table 4.8: Accuracy of the Horiba ABX Hematology Analyzers
Table 4.9: Linearity and Precision of Sysmex Hematology Analyzers
Table 4.10: Accuracy of the Sysmex Hematology Analyzers
Table 4.11: Comparison of Linearity and Precision of Top-of-the-Line Hematology Analyzers
Table 4.12: Comparison of Accuracy of the Top-of-the-Line Hematology Analyzers
Table 4.13: Hematology Analyzers with a 5-Part WBC Differential
Table 4.14: Hematology Analyzers with a Three-Part WBC Differential
Table 5.1: Applications for Wireless LAN Technology
Table 8.1: Medicare Billing Guidelines for Multi-channel Hematology Analyzer Tests

発刊日

2009/07/01

体裁

PDF / 147ページ

販売価格

3,400USD

発行

TriMark Publications

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

診断・検査薬

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE